DK1117420T3 - Farmaceutiske præparater baseret på alfa-cyclodextrin til oral indgivelse af LH-RH-analoge - Google Patents

Farmaceutiske præparater baseret på alfa-cyclodextrin til oral indgivelse af LH-RH-analoge

Info

Publication number
DK1117420T3
DK1117420T3 DK99948935T DK99948935T DK1117420T3 DK 1117420 T3 DK1117420 T3 DK 1117420T3 DK 99948935 T DK99948935 T DK 99948935T DK 99948935 T DK99948935 T DK 99948935T DK 1117420 T3 DK1117420 T3 DK 1117420T3
Authority
DK
Denmark
Prior art keywords
cyclodextrin
analogs
alpha
oral administration
pharmaceuticals based
Prior art date
Application number
DK99948935T
Other languages
Danish (da)
English (en)
Inventor
Remi Delansorne
Paule Bonnet
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DK1117420T3 publication Critical patent/DK1117420T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
DK99948935T 1998-09-30 1999-09-23 Farmaceutiske præparater baseret på alfa-cyclodextrin til oral indgivelse af LH-RH-analoge DK1117420T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (1)

Publication Number Publication Date
DK1117420T3 true DK1117420T3 (da) 2002-09-16

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948935T DK1117420T3 (da) 1998-09-30 1999-09-23 Farmaceutiske præparater baseret på alfa-cyclodextrin til oral indgivelse af LH-RH-analoge

Country Status (28)

Country Link
EP (2) EP0998940A1 (et)
JP (1) JP4485060B2 (et)
KR (1) KR100652457B1 (et)
CN (1) CN1200727C (et)
AR (1) AR023056A1 (et)
AT (1) ATE218358T1 (et)
AU (1) AU756233B2 (et)
BR (1) BR9914125A (et)
CA (1) CA2344470C (et)
CZ (1) CZ302343B6 (et)
DE (1) DE69901721T2 (et)
DK (1) DK1117420T3 (et)
EE (1) EE04872B1 (et)
ES (1) ES2178478T3 (et)
HK (1) HK1042047B (et)
HU (1) HUP0103649A3 (et)
ID (1) ID28650A (et)
IL (2) IL142112A0 (et)
MX (1) MXPA01003340A (et)
NO (1) NO330234B1 (et)
NZ (1) NZ510446A (et)
PL (1) PL200693B1 (et)
PT (1) PT1117420E (et)
RU (1) RU2214270C2 (et)
SI (1) SI1117420T1 (et)
TR (1) TR200100887T2 (et)
WO (1) WO2000018423A1 (et)
ZA (1) ZA200102452B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
ES2221019T3 (es) * 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU6199999A (en) 2000-04-17
HK1042047B (zh) 2005-12-16
NO330234B1 (no) 2011-03-07
HUP0103649A2 (hu) 2002-02-28
AR023056A1 (es) 2002-09-04
CN1324241A (zh) 2001-11-28
DE69901721D1 (de) 2002-07-11
EE200100196A (et) 2002-06-17
CN1200727C (zh) 2005-05-11
EP0998940A1 (en) 2000-05-10
NO20011576L (no) 2001-03-28
PT1117420E (pt) 2002-10-31
NO20011576D0 (no) 2001-03-28
MXPA01003340A (es) 2004-04-21
BR9914125A (pt) 2001-06-19
IL142112A0 (en) 2002-03-10
RU2214270C2 (ru) 2003-10-20
ATE218358T1 (de) 2002-06-15
AU756233B2 (en) 2003-01-09
DE69901721T2 (de) 2003-01-09
KR20010075255A (ko) 2001-08-09
CZ20011173A3 (cs) 2001-09-12
ES2178478T3 (es) 2002-12-16
ID28650A (id) 2001-06-21
CA2344470A1 (en) 2000-04-06
CA2344470C (en) 2009-01-06
HUP0103649A3 (en) 2002-05-28
PL200693B1 (pl) 2009-01-30
PL346939A1 (en) 2002-03-11
ZA200102452B (en) 2002-03-26
JP2002525336A (ja) 2002-08-13
NZ510446A (en) 2003-01-31
TR200100887T2 (tr) 2001-10-22
IL142112A (en) 2006-10-31
WO2000018423A1 (en) 2000-04-06
KR100652457B1 (ko) 2006-11-30
SI1117420T1 (en) 2002-12-31
EP1117420B1 (en) 2002-06-05
JP4485060B2 (ja) 2010-06-16
CZ302343B6 (cs) 2011-03-23
EP1117420A1 (en) 2001-07-25
EE04872B1 (et) 2007-08-15

Similar Documents

Publication Publication Date Title
DK0876131T3 (da) Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO20020976D0 (no) Retarderte, orale, farmasöytiske administreringsformer
NO992339L (no) Farmasöytiske formuleringer
NO20014035D0 (no) System for oral administrasjon av medikament
DK0679400T3 (da) Orale doseringsformer af azithromycin til undgåelse af lægemiddelfødevareinteraktion
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DK1083902T3 (da) Nye galeniske præparatformer af meloxicam til oral administrering
DE69819205D1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
EE9600118A (et) Uus peroraalne farmatseutiline annusvorm
ATE404207T1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
PT1221918E (pt) Administracao de drogas sub-tenon
ATE357941T1 (de) Vorrichtungen zur medikamentverabreichung
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
IS5730A (is) Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
DK0966299T3 (da) Hidtil ukendte orale formuleringer af calcitonin.
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
NO20002439D0 (no) Nye orale doseringsformer for carvediol
DK0994697T3 (da) Rapamycinformuleringer til oral indgivelse
DK0981340T3 (da) Farmaceutiske formuleringer i tør form til oral administration af en cyklisk kvaternær ammoniumforbindelse
GT200100033A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina.
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
DK1117420T3 (da) Farmaceutiske præparater baseret på alfa-cyclodextrin til oral indgivelse af LH-RH-analoge
DK1097159T3 (da) Phosphin- og phosphonsyrederivater som lægemidler
NO20003284L (no) Farmasøytisk preparat for oral administrering